3Greg Miller W, Myers GL, Lou Gantzer M, et al. Roadmap for harmonization of clinical laboratory measurement procedures. ClinChem,2011,57: 1105-1117.
4Luppa PB, Mtiller C, Schlichtiger A, et al. Point-of-care testing (POCT): Current techniques and future perspectives. Trends Analyt Chem,2011,30 : 888-898.
5CLSI. Point-of-care in vitro diagnostic testing. POCT4-A2. 2nd ed. Wayne, PA : CLSI.
6Freedman DB. Clinical governance: implications for polnt-of-care testing. Ann Clin Biochem,2002,39 : 421423.
7杨振华.即时检验.上海:上海科技出版社,2007:19.
8Westgard JO, Fallon KD, Mansouri S. Validation of IQM active process control technology. Point Care,2003,2: 1-7.
9Department of Health and Human Services.Health Care Finance Administration[S].Clinical Laboratory Improvement Amendments of 1988,final rule.Fed Hegist,1992:7001-7288.
10The National Committee for Clinical Laboratory Standards CLSI.C30-A:Ancillary (Bedside) Blood Glucose Testing in Acute and Chronic Care Facilities:Approved Guideline[S].Wayne:PA,CLSIC30 A,2002.
